ITRM20050344A1 - Sali o complessi di sostanze metil-donatrici con acido fitico o suoi derivati e relativo metodo di sintesi. - Google Patents

Sali o complessi di sostanze metil-donatrici con acido fitico o suoi derivati e relativo metodo di sintesi.

Info

Publication number
ITRM20050344A1
ITRM20050344A1 IT000344A ITRM20050344A ITRM20050344A1 IT RM20050344 A1 ITRM20050344 A1 IT RM20050344A1 IT 000344 A IT000344 A IT 000344A IT RM20050344 A ITRM20050344 A IT RM20050344A IT RM20050344 A1 ITRM20050344 A1 IT RM20050344A1
Authority
IT
Italy
Prior art keywords
phytic acid
salts
complexes
synthesis
derivatives
Prior art date
Application number
IT000344A
Other languages
English (en)
Italian (it)
Inventor
Luca Maria De
Original Assignee
Luca Maria De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luca Maria De filed Critical Luca Maria De
Priority to IT000344A priority Critical patent/ITRM20050344A1/it
Priority to PCT/IT2006/000484 priority patent/WO2007004244A1/en
Priority to PL06766355T priority patent/PL1896489T3/pl
Priority to DE602006004588T priority patent/DE602006004588D1/de
Priority to DK06766355T priority patent/DK1896489T3/da
Priority to AT06766355T priority patent/ATE419256T1/de
Priority to ES06766355T priority patent/ES2320489T3/es
Priority to JP2008519145A priority patent/JP4589999B2/ja
Priority to SI200630246T priority patent/SI1896489T1/sl
Priority to KR1020087001591A priority patent/KR101346974B1/ko
Priority to US11/923,000 priority patent/US8293254B2/en
Priority to EP06766355A priority patent/EP1896489B1/en
Priority to PT06766355T priority patent/PT1896489E/pt
Publication of ITRM20050344A1 publication Critical patent/ITRM20050344A1/it
Priority to CY20091100356T priority patent/CY1108929T1/el
Priority to JP2010115119A priority patent/JP5283659B2/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Seasonings (AREA)
IT000344A 2005-06-30 2005-06-30 Sali o complessi di sostanze metil-donatrici con acido fitico o suoi derivati e relativo metodo di sintesi. ITRM20050344A1 (it)

Priority Applications (15)

Application Number Priority Date Filing Date Title
IT000344A ITRM20050344A1 (it) 2005-06-30 2005-06-30 Sali o complessi di sostanze metil-donatrici con acido fitico o suoi derivati e relativo metodo di sintesi.
JP2008519145A JP4589999B2 (ja) 2005-06-30 2006-06-23 フィチン酸又はその誘導体とのメチル供与体の塩又は錯塩、及びその合成法
SI200630246T SI1896489T1 (sl) 2005-06-30 2006-06-23 Soli ali kompleksi donorjev metilne skupine s fitinsko kislino ali njenimi derivati in postopek za njihovo sintezo
DE602006004588T DE602006004588D1 (de) 2005-06-30 2006-06-23 Salze oder komplexe von methylspendern mit phytinsäure oder derivaten davon und verfahren zu deren synthese
DK06766355T DK1896489T3 (da) 2005-06-30 2006-06-23 Salte eller komplekser af methyldonorer med phytin-syre eller derivater deraf og fremgangsmåde til fremstilling deraf
AT06766355T ATE419256T1 (de) 2005-06-30 2006-06-23 Salze oder komplexe von methylspendern mit phytinsäure oder derivaten davon und verfahren zu deren synthese
ES06766355T ES2320489T3 (es) 2005-06-30 2006-06-23 Sales o complejos de donantes de grupos metilo con acido fitico o sus derivados y procedimiento para la sintesis de los mismos.
PCT/IT2006/000484 WO2007004244A1 (en) 2005-06-30 2006-06-23 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof
PL06766355T PL1896489T3 (pl) 2005-06-30 2006-06-23 Sole albo kompleksy donorów grupy metylowej z kwasem fitynowym albo jego pochodnymi oraz sposób ich syntezy
KR1020087001591A KR101346974B1 (ko) 2005-06-30 2006-06-23 피틴산 또는 피틴산의 유도체와 메틸 공여자의 염 또는 착염 및 이들의 제조 합성 방법
US11/923,000 US8293254B2 (en) 2005-06-30 2006-06-23 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof
EP06766355A EP1896489B1 (en) 2005-06-30 2006-06-23 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof
PT06766355T PT1896489E (pt) 2005-06-30 2006-06-23 Sais ou complexos de doadores de metilo com ácido fítico ou os seus derivados e método para a sua síntese
CY20091100356T CY1108929T1 (el) 2005-06-30 2009-03-26 Αλατα ή συμπλοκα δοτων μεθυλιου με φυτικο οξυ ή τα παραγωγα αυτου και μεθοδος για τη συνθεση αυτων
JP2010115119A JP5283659B2 (ja) 2005-06-30 2010-05-19 フィチン酸又はその誘導体とのメチル供与体の塩又は錯塩、及びその合成法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000344A ITRM20050344A1 (it) 2005-06-30 2005-06-30 Sali o complessi di sostanze metil-donatrici con acido fitico o suoi derivati e relativo metodo di sintesi.

Publications (1)

Publication Number Publication Date
ITRM20050344A1 true ITRM20050344A1 (it) 2007-01-01

Family

ID=39033793

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000344A ITRM20050344A1 (it) 2005-06-30 2005-06-30 Sali o complessi di sostanze metil-donatrici con acido fitico o suoi derivati e relativo metodo di sintesi.

Country Status (14)

Country Link
US (1) US8293254B2 (https=)
EP (1) EP1896489B1 (https=)
JP (2) JP4589999B2 (https=)
KR (1) KR101346974B1 (https=)
AT (1) ATE419256T1 (https=)
CY (1) CY1108929T1 (https=)
DE (1) DE602006004588D1 (https=)
DK (1) DK1896489T3 (https=)
ES (1) ES2320489T3 (https=)
IT (1) ITRM20050344A1 (https=)
PL (1) PL1896489T3 (https=)
PT (1) PT1896489E (https=)
SI (1) SI1896489T1 (https=)
WO (1) WO2007004244A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20060026A1 (it) * 2006-01-10 2007-07-11 Truffini & Regge Farmaceutici Srl Composizioni per uso rale a base di s-adenosilmetionina e processo per il loro ottenimento
ITMI20060629A1 (it) 2006-03-31 2007-10-01 Daniele Giovannone Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento
US9236938B2 (en) 2006-07-07 2016-01-12 Telefonaktiebolaget L M Ericsson (Publ) Resource allocation for co-existing networks
ITMI20071374A1 (it) * 2007-07-10 2009-01-11 Gnosis Spa Sali stabili di s-adenosilmetionina e processo per il loro ottenimento.
JP4598846B2 (ja) * 2008-07-14 2010-12-15 磐田化学工業株式会社 Ｓ−アデノシルメチオニン安定化のためのフィチン酸および／またはデキストリンを含む飲食用組成物
IT1393331B1 (it) * 2009-02-09 2012-04-20 Graal S R L Composizioni orosolubili e/o effervescenti contenenti almeno un sale di s-adenosilmetionina (same)
JP5573587B2 (ja) 2010-10-20 2014-08-20 株式会社デンソー 車両用回転電機
US9534010B2 (en) 2013-01-16 2017-01-03 Hebert Sam-E Llc Stable indole-3-propionate salts of S-adenosyl-L-methionine
ES2486441B1 (es) * 2014-04-02 2015-06-11 Universitat De Les Illes Balears Preparaciones combinadas de acidificantes urinarios e inhibidores de la cristalización y su aplicación para el tratamiento o prevención de la litiasis renal fosfática o inducida por fosfato cálcico
CA2995395C (en) 2015-08-31 2024-04-16 Nutramax Laboratories, Inc. Compositions comprising magnolia, phellodendron, theanine and/or whey protein
IT201700074957A1 (it) 2017-07-04 2019-01-04 Gnosis Spa Sale di (ss)-adenosil metionina con inositolo esafosfato e procedimento per ottenerlo
FR3068602B1 (fr) * 2017-07-10 2020-11-20 Guy Parc Nouveau traitement du cancer par une combinaison d'un derive phosphorique d'inositol et de chlorure de magnesium
EP3556398A1 (en) * 2018-04-16 2019-10-23 Croda Denmark A/S Phytates for use as a biomolecules delivery or adsorption system
JP2021046375A (ja) * 2019-09-19 2021-03-25 ポッカサッポロフード＆ビバレッジ株式会社 β３アドレナリン受容体活性化剤
CN115572309B (zh) * 2022-09-20 2024-05-03 浙江工业大学 一种高效阻燃、抗熔滴的环境友好型阻燃剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2824869A (en) * 1954-08-04 1958-02-25 Bristol Lab Inc Salt of streptomycin and phytic acid
US3019226A (en) * 1959-04-10 1962-01-30 Olin Mathieson Piperazine salt of phytic acid
US3242235A (en) * 1963-06-13 1966-03-22 Squibb & Sons Inc Phytate salts of the tetracyclines
IE39517B1 (en) * 1973-06-27 1978-10-25 Bioresearch Sas Double salts of s-adenosyl-l-methhionine
IT1200589B (it) * 1985-02-14 1989-01-27 Gibipharma Spa Derivati naturali attivita farmagologica
JPH0215032A (ja) * 1988-07-01 1990-01-18 Sanwa Kagaku Kenkyusho Co Ltd 肝疾患治療、予防剤及び強肝機能性飲食、し好物
US5434144A (en) * 1994-03-04 1995-07-18 The Procter & Gamble Company Methods of using cyclic polyanionic polyol derivatives for regulating skin wrinkles
IT1318535B1 (it) * 2000-05-25 2003-08-27 Chementecno Srl Processo per la preparazione di sali farmaceuticamente accettabili di(ss,rs)-s-adenosil-l-metionina.
US20030069202A1 (en) * 2000-06-02 2003-04-10 Kern Kenneth Norman Compositions, kits, and methods for promoting defined health benefits
US6610702B2 (en) * 2000-08-01 2003-08-26 Gmp Oxycell, Inc. Ammonium salts of inositol hexaphosphate, and uses thereof
JP2002145783A (ja) * 2000-11-06 2002-05-22 Kohjin Co Ltd Ｓ−アデノシルメチオニンまたはその塩類を含有するカプセル製剤
US20030078231A1 (en) * 2001-06-22 2003-04-24 Wilburn Michael D. Orthomolecular sulpho-adenosylmethionine derivatives with antioxidant properties
WO2003087109A1 (en) * 2002-04-12 2003-10-23 Silbiotec Due S.A. Medicaments containing glycerophosphoinositol-4-phosphate derivatives
US7135575B2 (en) * 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
DE602005013244D1 (de) * 2004-08-12 2009-04-23 Quest Pharmaceutical Services Pharmazeutische zusammensetzungen für die kontroll
US20060046982A1 (en) * 2004-08-26 2006-03-02 Waugh William H Orthomolecular medical use of L-citrulline for capillary endothelial protection and adjacent cell protection in neurodegenerative disease

Also Published As

Publication number Publication date
JP4589999B2 (ja) 2010-12-01
PT1896489E (pt) 2009-04-01
EP1896489A1 (en) 2008-03-12
ES2320489T3 (es) 2009-05-22
DK1896489T3 (da) 2009-04-20
WO2007004244A1 (en) 2007-01-11
PL1896489T3 (pl) 2009-06-30
JP2010235616A (ja) 2010-10-21
EP1896489B1 (en) 2008-12-31
US20090175914A1 (en) 2009-07-09
DE602006004588D1 (de) 2009-02-12
JP5283659B2 (ja) 2013-09-04
JP2009500319A (ja) 2009-01-08
ATE419256T1 (de) 2009-01-15
SI1896489T1 (sl) 2009-06-30
US8293254B2 (en) 2012-10-23
KR20080028949A (ko) 2008-04-02
CY1108929T1 (el) 2014-07-02
KR101346974B1 (ko) 2014-01-02

Similar Documents

Publication Publication Date Title
CY1108929T1 (el) Αλατα ή συμπλοκα δοτων μεθυλιου με φυτικο οξυ ή τα παραγωγα αυτου και μεθοδος για τη συνθεση αυτων
BR112021006229A2 (pt) composto, composição farmacêutica, e, método para tratamento de um câncer
CY1111045T1 (el) Μεθοδος παραγωγης ενος παραγωγου βενζιμιδαζολιου
CY1117950T1 (el) Μεθοδοι συνθεσης αματοξινων και δομικων λιθων αματοξινων
CL2010001368A1 (es) Compuestos derivados de 1,3-tiazina; composicion farmaceutica que lo comprende; utiles para inhibir a la beta-secretasa
UY30711A1 (es) Nuevos derivados de 1,4-benzotiepina-1, 1-cioxido, método para su preparacion, productos farmacéuticos que comprenden estos compuestos y su uso.-
BR112015021838A2 (pt) amatoxina, método de síntese, composição farmacêutica
BRPI0915692B8 (pt) compostos derivados de 1,2,5-oxadiazóis, sua forma sólida, sua composição, bem como seus usos
CR20140544A (es) Compuestos para inhibir la progresión mitotica
CY1111166T1 (el) Νεα παραγωγα 1,4-βενζοθειεπινο-1,1-διοξειδιου υποκατεστημενα με ριζες βενζυλιου, μεθοδοι διεργασιων για την παρασκευη τους, φαρμακα που περιεχουν αυτες τις ενωσεις και η χρηση τους
JO3172B1 (ar) تركيبة وطريقة وتحضير الصفراء الصناعية
MX2011009410A (es) Microcapsulas mejoradas y produccion de las mismas.
DE502006008627D1 (de) Verfahren zur herstellung ortho-metallierter metallverbindungen
GT200800285A (es) Aminopirazolopiridinas sustituidas y sus sales, sus preparaciones y composiciones farmaceuticas que las comprenden
BRPI0911404A2 (pt) Derivados de pirano, sua preparação e uso dos mesmos em perfumaria
EA201170282A1 (ru) Фунгицидные n-циколоалкил-n-бифенилметилкарбоксамидные производные
CO6420351A2 (es) Composiciones plaguicidas
CY1115094T1 (el) Νεα μεθοδος για την συνθεση (7-μεθοξυ-1-ναφθυλ) ακετονιτριλιου και εφαρμογη στην συνθεση αγομελατινης
AR058348A1 (es) Derivados de 1-aza-biciclo-nonano y composiciones farmaceuticas que los comprenden
CY1112520T1 (el) Βενζυλαμινες, μια διαδικασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδεις παραγοντες
BRPI0812022A2 (pt) Composições para produção de soja com teor de óleo elevado.
UY31460A1 (es) Procedimiento de preparacion de compuestos morfinicos
WO2007147163A3 (en) Compositions comprising carotenoid analogs or derivatives and methods for synthesis
AR064658A1 (es) Proceso para preparar duloxetina y sus compuestos relacionados, asi como tambien intermediarios utiles en la misma
UY29510A1 (es) Derivados de urea, metodos para su fabricación, y usos de los mismos